Tasly Pharmaceutical Group Co., Ltd
600535
Kedudukan dalam Saham
#4768
Tasly Pharmaceutical Group Co., Ltd., a company founded in 1994 and based in... Tasly Pharmaceutical Group Co., Ltd., a company founded in 1994 and based in Tianjin, China, is actively engaged in the biological medicine, health, and medical service industries within China. Its extensive product catalog encompasses a wide range of goods, including both traditional herbal and modern chemical medicines, alongside various health supplements. The firm also supplies key pharmaceutical ingredients (APIs), concentrated herbal granules, herbal extracts, and a diverse selection of tea products. Beyond its core pharmaceutical offerings, Tasly manufactures cosmetic lines featuring items such as moisturizing lotions, facial creams, eye creams, and cleansing foams. Additionally, its consumer goods division provides daily hygiene essentials like sanitary and carefree pads, in addition to specialized soaps made with honey-propolis and pollen. The company further distributes medical equipment, including different types of massage devices like tappers and cushions, as well as circulation-enhancing machines. Tasly's market presence extends globally, with significant exports directed to the United States, Russia, and numerous countries across Europe, Africa, and other parts of Asia.
Harga Saham
$2.06
Modal Pasaran
$3.08B
Perubahan (1 hari)
-0.93%
Perubahan (1 tahun)
-7.40%
Negara
CN
Perdagangan Tasly Pharmaceutical Group Co., Ltd (600535)
Kategori
Healthcare
Pendapatan untuk Tasly Pharmaceutical Group Co., Ltd (600535)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Tasly Pharmaceutical Group Co., Ltd, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Tasly Pharmaceutical Group Co., Ltd dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | ||
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
